Chemoinformaics analysis of Sulfoquinovosyl diglyceride
| Molecular Weight | 841.158 | nRot | 35 |
| Heavy Atom Molecular Weight | 764.55 | nRig | 15 |
| Exact Molecular Weight | 840.506 | nRing | 1 |
| Solubility: LogS | -2.112 | nHRing | 1 |
| Solubility: LogP | 7.049 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 134 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 76 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 45 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 138.35 |
| nHD | 4 | BPOL | 91.5797 |
| QED | 0.021 |
| Synth | 5.028 |
| Natural Product Likeliness | 1.057 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.343 |
| HIA | 0.889 |
| CACO-2 | -5.413 |
| MDCK | 0.0000104 |
| BBB | 0.002 |
| PPB | 1.02957 |
| VDSS | 0.575 |
| FU | 0.0100007 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.043 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.243 |
| CYP2c9-sub | 0.998 |
| CYP2d6-inh | 0.098 |
| CYP2d6-sub | 0.034 |
| CYP3a4-inh | 0.645 |
| CYP3a4-sub | 0.012 |
| CL | 1.594 |
| T12 | 0.769 |
| hERG | 0.524 |
| Ames | 0.002 |
| ROA | 0.001 |
| SkinSen | 0.991 |
| Carcinogencity | 0.142 |
| EI | 0.064 |
| Respiratory | 0.905 |
| NR-Aromatase | 0.617 |
| Antiviral | Yes |
| Prediction | 0.693292 |